Featured Research

from universities, journals, and other organizations

NASA signs agreement to develop nasal spray for motion sickness

Date:
October 12, 2012
Source:
NASA
Summary:
NASA's Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness. Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition.

NASA's Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.

Related Articles


Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With a precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form.

"NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas," said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson.

A gel formulation of INSCOP was developed and tested under a Space Act Agreement between Johnson and the Naval Aerospace Medical Research Laboratory in Pensacola, Fla. Results from that trial were published in the journal Aviation, Space and Environmental Medicine in April 2010 that suggest INSCOP is a fast-acting and reliable way to prevent and treat motion sickness.

The U.S. Navy is working on an agreement with Epiomed to test the nasal spray. NASA and Epiomed will collaborate on clinical trials related to the Federal Drug Administration requirements. NASA is transferring sponsorship of future clinical trials and FDA approvals to Epiomed, which will supply the product for use by NASA and others.

For more about Johnson's Human Health and Performance Directorate, which developed INSCOP, visit: http://go.nasa.gov/RiKclM


Story Source:

The above story is based on materials provided by NASA. Note: Materials may be edited for content and length.


Cite This Page:

NASA. "NASA signs agreement to develop nasal spray for motion sickness." ScienceDaily. ScienceDaily, 12 October 2012. <www.sciencedaily.com/releases/2012/10/121012152519.htm>.
NASA. (2012, October 12). NASA signs agreement to develop nasal spray for motion sickness. ScienceDaily. Retrieved March 27, 2015 from www.sciencedaily.com/releases/2012/10/121012152519.htm
NASA. "NASA signs agreement to develop nasal spray for motion sickness." ScienceDaily. www.sciencedaily.com/releases/2012/10/121012152519.htm (accessed March 27, 2015).

Share This


More From ScienceDaily



More Space & Time News

Friday, March 27, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Supermassive Blackhole Detector Ready for Business

Supermassive Blackhole Detector Ready for Business

Reuters - Innovations Video Online (Mar. 25, 2015) Construction of the world&apos;s largest and most powerful observatory designed to detect and analyze gamma rays has been completed in Mexico. Gamma ray particles are considered the most energetic in the universe and scientists hope to use the observatory to learn more about the supernovas and black holes that produce them. Ben Gruber reports. Video provided by Reuters
Powered by NewsLook.com
Rocket Blasts Off Carrying U.S. Air Force GPS Satellite

Rocket Blasts Off Carrying U.S. Air Force GPS Satellite

Reuters - News Video Online (Mar. 25, 2015) A U.S. Air Force GPS IIF-9 satellite launches aboard a United Launch Alliance Delta IV rocket into semi-synchronous orbit. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Opportunity's Marathon: The Mars Rover Just Keeps Going

Opportunity's Marathon: The Mars Rover Just Keeps Going

Newsy (Mar. 24, 2015) NASA&apos;s Opportunity Mars Rover finished a full marathon, making it the first human creation to do a full 26.2 miles on another planet. Video provided by Newsy
Powered by NewsLook.com
Twin Astronaut to Break NASA Record in Study

Twin Astronaut to Break NASA Record in Study

AP (Mar. 23, 2015) NASA astronaut Scott Kelly will be the first American to spend a year aboard the International Space Station in an experiment to test human endurance in space, while his twin brother&apos;s health is compared on Earth. (March 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins